1. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990.CA CancerJ Clin. 1990;40(1):9-26.
2. Gusberg SB. Diagnosis and principles of treatment of cancer of theendometrium. in: Gusberg SB, Shingleton HM, Deppe G, eds. Femalegenital cancer. New York: Churchill 337, 1988.
3. Gokmen Karasu AF, Ates S, Gurbuz T, Sahin N, Takmaz T, Aydin S.“A Clinico-Pathological Study of Transvaginal Endometrial ThicknessMeasurement in Asymptomatic Postmenopausal Patients and PatientsWith Postmenopausal Bleeding”.Gynecol Obstet Reprod Med. 2019;25(2): 85-88. doi:10.21613/GORM.2018.851.
4. Haltia UM, Bützow R, Leminen A, Loukovaara M. FIGO 1988versus 2009 staging for endometrial carcinoma: a comparativestudy on prediction of survival and stage distribution according tohistologic subtype.J Gynecol Oncol. 2014;25(1):30-35. doi:10.3802/jgo.2014.25.1.30
5. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging inendometrial cancer: clinical-pathologic findings of a prospectivestudy.Obstet Gynecol. 1984;63(6):825-832.
6. Abeler VM, Kjørstad KE. Endometrial adenocarcinoma in Norway. Astudy of a total population.Cancer. 1991;67(12):3093-3103. doi:10.1002/10970142(19910615) 67:12<3093::aid-cncr2820671226>3.0.co;2-l
7. DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors andrecurrent patterns in Stage I endometrial cancer.Am J Obstet Gynecol.1985;151(8):1009-1015. doi:10.1016/0002-9378(85)90371-0
8. Sironi S, Taccagni G, Garancini P, Belloni C, DelMaschio A. Myometrialinvasion by endometrial carcinoma: assessment by MR imaging.AJRAm J Roentgenol. 1992;158(3):565-569. doi:10.2214/ajr.158.3.1738995
9. Dore R, Moro G, D’Andrea F, La Fianza A, Franchi M, Bolis PF. CTevaluation of myometrium invasion in endometrial carcinoma.JComput Assist Tomogr. 1987;11(2):282-289. doi:10.1097/00004728-198703000-00018
10. Sutton GP, Geisler HE, Stehman FB, Young PC, Kimes TM, EhrlichCE. Features associated with survival and disease-free survival inearly endometrial cancer.Am J Obstet Gynecol. 1989;160(6):1385-1393.doi:10.1016/0002-9378(89)90859-4
11. Kaku T, Tsuruchi N, Tsukamoto N, Hirakawa T, Kamura T, Nakano H.Reassessment of myometrial invasion in endometrial carcinoma.ObstetGynecol. 1994;84(6):979-982.
12. Gordon AN, Fleischer AC, Reed GW. Depth of myometrial invasionin endometrial cancer: preoperative assessment by transvaginalultrasonography.Gynecol Oncol. 1990;39(3):321-327. doi:10.1016/0090-8258(90)90260-r
13. Ozdemir S, Celik C, Emlik D, Kiresi D, Esen H. Assessmentof myometrial invasion in endometrial cancer by transvaginalsonography, Doppler ultrasonography, magnetic resonance imagingand frozen section.Int J Gynecol Cancer. 2009;19(6):1085-1090.doi:10.1111/IGC.0b013e3181ad3eb6.
14. Savelli L, Testa AC, Mabrouk M, et al. A prospective blinded comparisonof the accuracy of transvaginal sonography and frozen section in theassessment of myometrial invasion in endometrial cancer.GynecolOncol. 2012;124(3):549-552. doi:10.1016/j.ygyno.2011.11.016
15. Rei M, Rodrigues I, Condeço P, Igreja F, Veríssimo C, MendinhosG. Endometrial cancer: Preoperative versus intraoperative staging[published online ahead of print, 2019 Nov 21].J Gynecol Obstet HumReprod. 2019;101647. doi:10.1016/j.jogoh.2019.101647
16. Jónsdóttir B, Marcickiewicz J, Borgfeldt C, et al. Preoperative andintraoperative assessment of myometrial invasion in endometrialcancer-A Swedish Gynecologic Cancer Group (SweGCG) study.ActaObstet Gynecol Scand. 2021;100(8):1526-1533. doi:10.1111/aogs.14146
17. Signorelli M, Lissoni AA, Cormio G, et al. Modified radicalhysterectomy versus extrafascial hysterectomy in the treatment of stageI endometrial cancer: results from the ILIADE randomized study.AnnSurg Oncol. 2009;16(12):3431-3441. doi:10.1245/s10434-009-0736-6
18. Saygili U, Kavaz S, Altunyurt S, Uslu T, Koyuncuoglu M, Erten O.Omentectomy, peritoneal biopsy and appendectomy in patientswith clinical stage I endometrial carcinoma.Int J Gynecol Cancer.2001;11(6):471-474. doi:10.1046/j.1525-1438.2001.01065.x
19. Fujiwara H, Saga Y, Takahashi K, et al. Omental metastases inclinical stage I endometrioid adenocarcinoma.Int J Gynecol Cancer.2008;18(1):165-167. doi:10.1111/j.1525-1438.2007.00961.x